Ahmud MW, Mustafa M, Asim W. A rare disease gets a breakthrough: Ctexli approved for cerebrotendinous xanthomatosis. Int J Basic Clin Pharmacol [Internet]. 2025 Jun. 24 [cited 2025 Oct. 23];14(4):649-50. Available from: https://www.ijbcp.com/index.php/ijbcp/article/view/5908